Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 244.00 | 243.75 | 1.0010 | 1.0047 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 312.50 | 180.13 | 180.00 | 243.75 | 0.7385 | -0.0016 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 252.00 | 243.75 | 1.0338 | 1.1585 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 271.00 | 243.75 | 1.1118 | 1.5497 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 492.00 | 582.00 | 0.8454 | 0.5505 | |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 680.00 | 582.00 | 1.1684 | 1.5320 | |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 625.00 | 368.38 | 255.00 | 582.00 | 0.4381 | -0.4273 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 520.00 | 582.00 | 0.8935 | 0.6861 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 625.00 | 368.38 | 642.00 | 582.00 | 1.1031 | 1.3206 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 625.00 | 368.38 | 663.00 | 582.00 | 1.1392 | 1.4367 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 625.00 | 368.38 | 864.00 | 582.00 | 1.4845 | 2.6398 |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 4 | 625.00 | 368.38 | 339.00 | 582.00 | 0.5825 | -0.1183 |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 625.00 | 368.38 | 281.00 | 582.00 | 0.4828 | -0.3366 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 625.00 | 368.38 | 746.00 | 582.00 | 1.2818 | 1.9136 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 625.00 | 368.38 | 569.00 | 582.00 | 0.9777 | 0.9327 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 4 | 625.00 | 368.38 | 2485.00 | 582.00 | 4.2698 | 17.0473 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 625.00 | 368.38 | 803.00 | 582.00 | 1.3797 | 2.2575 |
| SK-BR-3 | 0 | uM | 4 | 625.00 | 368.38 | 790.00 | 582.00 | 1.3574 | 2.1779 | |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 625.00 | 368.38 | 604.00 | 582.00 | 1.0378 | 1.1157 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 625.00 | 368.38 | 571.00 | 582.00 | 0.9811 | 0.9430 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 625.00 | 368.38 | 758.00 | 582.00 | 1.3024 | 1.9849 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 4 | 625.00 | 368.38 | 294.00 | 582.00 | 0.5052 | -0.2895 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 4 | 625.00 | 368.38 | 429.00 | 582.00 | 0.7371 | 0.2597 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 625.00 | 368.38 | 584.00 | 582.00 | 1.0034 | 1.0104 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 625.00 | 368.38 | 512.00 | 582.00 | 0.8797 | 0.6470 |